Autopsy report · NCT01439542

FASTR: Fairly Brief Androgen Suppression and Stereotactic Radiotherapy for High Risk Prostate Cancer

Cause of deathSafety Automatic label, confidence 0.9, unverified. How labels are made.

“Higher then expected Gr3 GU/GI toxicity”

The sponsor’s own words in the registry.

Life of this trial

Ran for about 6 years 2 months before it stopped.
19 participants enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Phase: Phase 2
Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Sponsor type: University, hospital or other
Conditions: Prostate Cancer
Interventions: Stereotactic Body Radiation; Luteinizing Hormone Releasing Hormone (LHRH) Agonist
Participants: 19
Sites: 1
Countries: Canada

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.